Does Coronary Vasospasm Show a Better Prognosis in Out of Hospital Cardiac Arrest: Data from the Korean Cardiac Arrest Research Consortium (KoCARC) Registry

Background: Previous cohort studies focused on relative risk stratification among patients diagnosed with vasospastic angina, and it is unknown how much vasospasm accounts for the cause of out-of-hospital cardiac arrest, and whether prognosis differs. Methods: From a registry data collected from 65 hospitals in Korea, 863 subjects who survived hospital cardiac arrest were evaluated. The patients with insignificant coronary lesion, vasospasm, and obstructive lesion were each grouped as group I, group II, and group III, respectively. The primary and secondary outcomes were survival to hospital discharge and good neurological function at discharge defined as cerebral performance index 1. Results: At hospital discharge, 529 subjects (61.3%) survived. There was no significant difference in survival according to coronary angiographic findings (P = .133 and P = .357, group II and group III compared to group I), but the neurological outcome was significantly better in groups II and III (P = .046 and P = .022, groups II and III compared to group I). Two multivariate models were evaluated to adjust traditional risk factors and cardiac biomarkers. The presence of coronary artery vasospasm did not affect survival to hospital discharge (P = 0.060 and P = .162 for both models), but neurological function was significantly better (OR: 1.965, 95% CI: 1.048-3.684, P = .035, and OR: 1.706, 95% CI: 1.012-2.878, P = .045 for vasospasm, models I and II, respectively). Conclusions: Coronary vasospasm does not show better survival to hospital discharge, but shows better neurological outcomes. Aggressive coronary angiography and intensive medical treatment for adequate control of vasospasm should be emphasized to prevent and manage fatal events.

[1]  E. Guallar,et al.  Differential prognosis of vasospastic angina according to presentation with sudden cardiac arrest or not: Analysis of the Korean Health Insurance Review and Assessment Service. , 2018, International journal of cardiology.

[2]  H. Teragawa,et al.  Coronary spasm: It’s common, but it’s still unsolved , 2018, World journal of cardiology.

[3]  Seil Oh,et al.  Korean Cardiac Arrest Research Consortium (KoCARC): rationale, development, and implementation , 2018, Clinical and experimental emergency medicine.

[4]  É. Marijon,et al.  Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation , 2018, European heart journal.

[5]  T. Shindo,et al.  Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina. , 2018, Journal of the American College of Cardiology.

[6]  J. Indik True or False: Prognosis Is Excellent for Sudden Cardiac Death Survivors Due to Variant Angina. , 2016, Journal of the American College of Cardiology.

[7]  J. Cho,et al.  Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death. , 2016, Journal of the American College of Cardiology.

[8]  K. Sakamoto,et al.  Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm , 2016, Journal of the American Heart Association.

[9]  B. McNally,et al.  Early Coronary Angiography and Survival After Out-of-Hospital Cardiac Arrest , 2015, Circulation. Cardiovascular interventions.

[10]  Barbara T. Unger,et al.  Outcomes of Comatose Cardiac Arrest Survivors With and Without ST-Segment Elevation Myocardial Infarction: Importance of Coronary Angiography. , 2015, JACC. Cardiovascular interventions.

[11]  H. Shimokawa 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside. , 2014, European heart journal.

[12]  Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[13]  S. Miyata,et al.  Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association. , 2013, Journal of the American College of Cardiology.

[14]  J. Ravkilde,et al.  Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest--a systematic review and meta-analysis. , 2012, Resuscitation.

[15]  H. Shimokawa,et al.  Clinical Characteristics and Long-Term Prognosis of Vasospastic Angina Patients Who Survived Out-of-Hospital Cardiac Arrest: Multicenter Registry Study of the Japanese Coronary Spasm Association , 2011, Circulation. Arrhythmia and electrophysiology.

[16]  R. Berg,et al.  Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. , 2010, Resuscitation.

[17]  A. D. de Luna,et al.  Coronary Artery Spasm: A 2009 Update , 2009, Circulation.

[18]  M. Horie,et al.  Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. , 2008, Journal of the American College of Cardiology.

[19]  H. Yasue,et al.  Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. , 2008, Journal of cardiology.

[20]  K. Chayama,et al.  Endothelial dysfunction is an independent factor responsible for vasospastic angina. , 2001, Clinical science.

[21]  F. Ohsuzu,et al.  Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of vitamin C. , 2001, The American journal of cardiology.

[22]  K. Kugiyama,et al.  Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina. , 2001, Journal of the American College of Cardiology.

[23]  K. Kugiyama,et al.  Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. , 2001, American journal of physiology. Heart and circulatory physiology.

[24]  G. Kajiyama,et al.  The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. , 2000, Chest.

[25]  K. Nakao,et al.  Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-->C and missense Glu298Asp variants. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[26]  A. Maseri,et al.  Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. , 1999, Journal of the American College of Cardiology.

[27]  D. Zahger Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. , 1997, The New England journal of medicine.

[28]  T. Ueda,et al.  Relation between severity of magnesium deficiency and frequency of anginal attacks in men with variant angina. , 1996, Journal of the American College of Cardiology.

[29]  H. Inoue,et al.  Vitamin E deficiency in variant angina. , 1996, Circulation.

[30]  H. Ishizaka,et al.  Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. , 1992, Journal of the American College of Cardiology.

[31]  A. Castellanos,et al.  Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. , 1992, The New England journal of medicine.

[32]  K. Okumura,et al.  Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. , 1989, Circulation.

[33]  M. Horie,et al.  Long-term prognosis for patients with variant angina and influential factors. , 1988, Circulation.

[34]  H. Yasue,et al.  Role of Autonomic Nervous System in the Pathogenesis of Prinzmetal's Variant Form of Angina , 1974, Circulation.

[35]  M. Prinzmetal,et al.  Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.